Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study

Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study

Bibliographic Details
Main Authors:	Kim, Se Hyun, Jung, Kyung Hae, Kim, Tae-Yong, Im, Seock-Ah, Choi, In Sil, Chae, Yee Soo, Baek, Sun Kyung, Kang, Seok Yun, Park, Sarah, Park, In Hae, Lee, Keun Seok, Choi, Yoon Ji, Lee, Soohyeon, Sohn, Joo Hyuk, Park, Yeon-Hee, Im, Young-Hyuck, Ahn, Jin-Hee, Kim, Sung-Bae, Kim, Jee Hyun
Format:	Online
Language:	English
Published:	Korean Cancer Association 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080811/

Similar Items

S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial
by: Moon, Yong Wha, et al.
Published: (2013)

ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy
by: Kim, Hee-Jun, et al.
Published: (2015)

Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy
by: Kim, Chang Gon, et al.
Published: (2016)

A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer
by: Yoo, Changhoon, et al.
Published: (2015)

Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer
by: Hong, Woo Sung, et al.
Published: (2013)

The relationship between nuclear factor (NF)-κB family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment
by: Kim, Ji-Yeon, et al.
Published: (2016)

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
by: Keam, Bhumsuk, et al.
Published: (2007)

Comparison of Doxorubicin Plus Docetaxel Neoadjuvant Chemotherapy with Doxorubicin Plus Vinorelbine in Primary Breast Cancer
by: Gwak, Geumhee, et al.
Published: (2011)

Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay
by: Park, Kyunghee, et al.
Published: (2015)

Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency
by: Jung, Hae Hyun, et al.
Published: (2016)

Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes
by: Kim, Sang-Won, et al.
Published: (2016)

Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer
by: Yoo, Changhoon, et al.
Published: (2016)

Effect of Time Interval between Breast-Conserving Surgery and Radiation Therapy on Outcomes of Node-Positive Breast Cancer Patients Treated with Adjuvant Doxorubicin/Cyclophosphamide Followed by Taxane
by: Koh, Hyeon Kang, et al.
Published: (2016)

Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer
by: Kim, Ji-Yeon, et al.
Published: (2016)

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
by: Lee, Kyung-Hun, et al.
Published: (2007)

Can we omit prophylactic inguinal nodal irradiation in anal cancer patients?
by: Kim, Hakyoung, et al.
Published: (2015)

Prognostic Nomogram for Prediction of Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy in Cytologically Proven Node-Positive Breast Cancer
by: Kim, Jee Ye, et al.
Published: (2015)

Survival Benefits of Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy in Locally Advanced Chemoresistant Cervical Cancer
by: Choi, Youn Seok, et al.
Published: (2006)

A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09
by: Lee, Ki Hyeong, et al.
Published: (2015)

High-dose Versus Low-dose Cyclophosphamide in Combination with G-CSF for Peripheral Blood Progenitor Cell Mobilization
by: Ahn, Jin Seok, et al.
Published: (2005)

A call for action from workers, local residents, and consumers: a safe society from toxic chemicals
by: Kim, Shinbum, et al.
Published: (2016)

Prognostic impact of sarcopenia in patients with diffuse large B‐cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
by: Go, Se‐Il, et al.
Published: (2016)

Prognostic value of ERBB4 expression in patients with triple negative breast cancer
by: Kim, Ji-Yeon, et al.
Published: (2016)

Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer
by: Seo, An Na, et al.
Published: (2016)

Processed Aloe vera Gel Ameliorates Cyclophosphamide-Induced Immunotoxicity
by: Im, Sun-A, et al.
Published: (2014)

Blockade of Interplay between IL-17A and Endoplasmic Reticulum Stress Attenuates LPS-Induced Lung Injury
by: Kim, So Ri, et al.
Published: (2015)

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth
by: Lee, Eun Ju, et al.
Published: (2014)

Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting
by: Choi, Jin-Seok, et al.
Published: (2016)

Radiation Treatment in Pathologic N0-N1 Patients Treated with Neoadjuvant Chemotherapy Followed by Surgery for Locally Advanced Breast Cancer
by: Bae, Sun Hyun, et al.
Published: (2012)

Clinical implication of Time To Brain Metastasis (TTBM) according to breast cancer subtypes
by: Ahn, Hee Kyung, et al.
Published: (2013)

The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC)
by: Lee, Ji Yun, et al.
Published: (2016)

Genotypes of Clinical and Environmental Isolates of Cryptococcus neoformans and Cryptococcus gattii in Korea
by: Park, So Hae, et al.
Published: (2015)

Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients
by: Yoon, Jung Hyun, et al.
Published: (2013)

Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer
by: Park, Yeon Hee, et al.
Published: (2015)

Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer
by: Hyun, Seung Hyup, et al.
Published: (2016)

Fine-Needle Aspirate CYFRA 21-1, an Innovative New Marker for Diagnosis of Axillary Lymph Node Metastasis in Breast Cancer Patients
by: Choi, Ji Soo, et al.
Published: (2015)

Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer
by: Lee, Ji Yun, et al.
Published: (2015)

Determination of Heterocyclic Amines and Acrylamide in Agricultural Products with Liquid Chromatography-Tandem Mass Spectrometry
by: Lee, Kyung-Jun, et al.
Published: (2015)

Correction of Pincer Nail Deformity Using Dermal Grafting
by: Nam, Hyun Min, et al.
Published: (2011)

Comparison of Calcium Intake Status by Region and Socioeconomic Status in Korea: The 2011-2013 Korea National Health and Nutrition Examination Survey
by: Lim, Hee-Sook, et al.
Published: (2015)